This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of drugs targeting central nervous system disorders, such as anxiety, depression, and neurodegenerative diseases. Its structural properties make it a suitable building block for creating molecules that interact with specific receptors or enzymes in the brain, enhancing therapeutic efficacy. Additionally, it may be employed in research settings for the development of novel compounds with potential pharmacological activity, aiding in the discovery of new treatments for complex medical conditions.